CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer

Hye Ryeon Kim, Su Jin Lee, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Han-Sin Jeong, Man Ki Chung, Myung-Ju Ahn

Cancer Research and Treatment. 2022;54(3):719-727. Published online 2021 November 1 DOI: https://doi.org/10.4143/crt.2021.1019

A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer

Hye Ryeon Kim, Su Jin Lee, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Han-Sin Jeong, Man Ki Chung, Myung-Ju Ahn

Cancer Research and Treatment. 2022;54(3):719-727

Link1

Link2 Link3

A Prospective Multicenter Phase II Study of Cisplatin and Weekly Docetaxel as First-Line Treatment of Recurrent or Metastatic NAsopharyngeal Cancer (KCSG HN07-01)

J.H. Ji

Annals of Oncology. 2012;23:xi156

Link1 Link2

2300 A multicenter randomized phase II study of docetaxel vs. docetaxel plus cisplatin vs. docetaxel plus S-1 as second-line chemotherapy in metastatic gastric cancer patients who had progressed after cisplatin plus either S-1 or capecitabine

B. Kim, K.W. Lee, M.J. Kim, H.S. Han, Y.L. Park, S.R. Park

European Journal of Cancer. 2015;51:S432

Link1 Link2

1031 POSTER Weekly chemotherapy with cisplatin and docetaxel for recurrent metastatic head and neck cancer: a phase II study

European Journal of Cancer Supplements. 2005;3(2):297

Link1 Link2

Phase II Study of Weekly Docetaxel and Cisplatin in Patients With Advanced Recurrent and Metastatic Head and Neck Cancer

Orlando Guntinas-Lichius, Stefan Appenrodt, Florian Veelken, Barbara Krug

The Laryngoscope. 2006;116(4):613-618

Link1 Link2

A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine

Keun-Wook Lee, Bum Jun Kim, Mi-Jung Kim, Hye Sook Han, Jin Won Kim, Young Iee Park, Sook Ryun Park

Cancer Research and Treatment. 2017;49(3):706-716

Link1

Link2 Link3

147PD A PHASE II STUDY OF WEEKLY PACLITAXEL PLUS GEMCITABINE AS SECOND-LINE THERAPY IN PATIENTS WITH METASTATIC OR RECURRENT SMALL CELL LUNG CANCER (SCLC)

H.T. Kim, T. Yun, J. Han, H.L. Choi, H.Y. Kim, J.S. Lee

Lung Cancer. 2009;64:S62

Link1 Link2

A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer

Jin Young Kim, Young Rok Do, Keon Uk Park, Min Kyung Kim, Kyung Hee Lee, Sung Hwa Bae, Hun Mo Ryoo, Jin Ho Baek, Hong Suk Song

Cancer Chemotherapy and Pharmacology. 2009;66(1):31-36

Link1

Link2 Link3

Anlotinib plus chemotherapy as first-line treatment for advanced ovarian cancer: a prospective, single-arm, single-center, phase II clinical study

Dechun Liu, Master, tao yan, Qian Zhang

Gynecologic Oncology. 2021;162:S89-S90

Link1 Link2

Phase II Trial of Weekly Docetaxel/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer

Joyce A. O'Shaughnessy, Robert Pluenneke, Jack Sternberg, Pankaj Khandelwal, Des Ilegbodu, Lina Asmar

Clinical Breast Cancer. 2006;6(6):505-510

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.